Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed second-quarter earnings picture, with adjusted earnings surpassing analyst ...

Merck’s stock is falling after a rare revenue miss, and the announcement of a $3 billion cost-cutting plan that will include layoffs.

Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027 By Kevin Dunleavy Jul 29, 2025 8:15am Merck layoffs Keytruda Gardasil ...

Merck plans to pay $107 for each Verona Pharma American Depository Share, which represents eight of the company’s ordinary shares. The deal announced Wednesday has been approved by the boards of ...

The Math Still Doesn’t Add Up Although this acquisition signifies progress, it’s evidently insufficient to resolve Merck’s fundamental issue. The company anticipates a potential $15-20 ...

Key Points Merck aims to boost its business by buying Verona Pharma for $10 billion.Through the deal, it will add Ohtuvayre -- a treatment for COPD -- to its portfolio.With the stock valued at ...